ArticleAnnals of the rheumatic diseases2003

Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures.

O Elkayam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.